Summary
Treatment with albiglutide in combination with metformin was superior to sitagliptin and glimepiride for reduction of HbA1C and fasting plasma glucose levels in patients with type 2 diabetes mellitus. This article presents data from the Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes trial [HARMONY 3; NCT00838903].
- Diabetes Mellitus
- Diabetes & Endocrinology Clinical Trials
- Diabetes Mellitus
- Diabetes & Endocrinology Clinical Trials
- Endocrinology
- Diabetes & Metabolic Syndrome
- © 2013 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.